MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...
Bayer & Soufflé Therapeutics enter strategic collaboration to advance cell-specific heart-targeted siRNA therapy: Berlin, Germany Friday, January 9, 2026, 09:00 Hrs [IST] Bayer a ...
A subgroup analysis of the phase 3 FOCUS study (NCT02678572) shows that the Melphalan/Hepatic Delivery System (HDS; HEPZATO ...
Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...
When a breakout hits now, the smartest move is a targeted acne spot treatment designed to calm, treat, and heal—without ...
In the swiftly evolving field of artificial intelligence (AI), the technology's capability to revolutionize care processes in ...
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...
Discover how High-Intensity Focused Ultrasound (HIFU) treatment is revolutionizing care for prostate cancer and tumours with ...
Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...
SurvivorNet on MSN
Targeted therapy in a shot: New approval for EGFR-mutated lung cancer can improve day-to-day life for patients
Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback